Short-term memory of danger signals and environmental stimuli in immune cells

Nature Immunology

Volumn 14, Issue 8, 2013, Pages 777-784

  Monticelli, Silvia ^a   Natoli, Gioacchino ^b  

^a INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE; HISTONE H3; LONG UNTRANSLATED RNA; MICRORNA; STAT1 PROTEIN; STAT4 PROTEIN;

CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL STIMULATION; CHROMATIN; DAUGHTER CELL; DNA METHYLATION; ENVIRONMENTAL EXPOSURE; HISTONE ACETYLATION; HISTONE METHYLATION; HISTONE MODIFICATION; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOLOGICAL MEMORY; NONHUMAN; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER; SHORT TERM MEMORY;

ADAPTIVE IMMUNITY; CHROMATIN; ENVIRONMENTAL EXPOSURE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; MEMORY, SHORT-TERM; MICRORNAS;

EID: 84880815366     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.2636     Document Type: Review

References (131)

1. Biswas, S.K. & Lopez-Collazo, E. Endotoxin tolerance: New mechanisms, molecules and clinical significance. Trends Immunol. 30, 475-487 (2009).
2. del Fresno, C. et al. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: Demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 182, 6494-6507 (2009).
3. Limaye, A.P. et al. Cytomegalovirus reactivation in critically ill immunocompetent patients. J. Am. Med. Assoc. 300, 413-422 (2008).
4. van der Poll, T. & Opal, S.M. Host-pathogen interactions in sepsis. Lancet Infect. Dis. 8, 32-43 (2008).
5. Hottiger, M.O., Felzien, L.K. & Nabel, G.J. Modulation of cytokine-induced HIV gene expression by competitive binding of transcription factors to the coactivator p300. EMBO J. 17, 3124-3134 (1998).
6. Ghisletti, S. et al. Identification and characterization of enhancers controlling the inflammatory gene expression program in macrophages. Immunity 32, 317-328 (2010).
7. Hazzalin, C.A. & Mahadevan, L.C. Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: Analysis at c-fos and c-jun. PLoS Biol. 3, e393 (2005).
8. Bernstein, B.E., Meissner, A. & Lander, E.S. The mammalian epigenome. Cell 128, 669-681 (2007).
9. Zee, B.M., Levin, R.S., Dimaggio, P.A. & Garcia, B.A. Global turnover of histone post-translational modifications and variants in human cells. Epigenetics Chromatin 3, 22 (2010).
10. Zee, B.M. et al. In vivo residue-specific histone methylation dynamics. J. Biol. Chem. 285, 3341-3350 (2009).
11. Ostuni, R. et al. Latent enhancers activated by stimulation in differentiated cells. Cell 152, 157-171 (2013).
12. Quintin, J. et al. Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12, 223-232 (2012).
13. Ruthenburg, A.J., Allis, C.D. & Wysocka, J. Methylation of lysine 4 on histone H3: Intricacy of writing and reading a single epigenetic mark. Mol. Cell 25, 15-30 (2007).
14. Hargreaves, D.C., Horng, T. & Medzhitov, R. Control of inducible gene expression by signal-dependent transcriptional elongation. Cell 138, 129-145 (2009).
15. De Santa, F. et al. Jmjd3 contributes to the control of gene expression in LPS-activated macrophages. EMBO J. 28, 3341-3352 (2009).
16. Byun, J.S. et al. Dynamic bookmarking of primary response genes by p300 and RNA polymerase II complexes. Proc. Natl. Acad. Sci. USA 106, 19286-19291 (2009).
17. Heintzman, N. et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 39, 311-318 (2007).
18. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
19. Visel, A. et al. ChIP-seq accurately predicts tissue-specific activity of enhancers. Nature 457, 854-858 (2009).
20. Boyle, A.P. et al. High-resolution mapping and characterization of open chromatin across the genome. Cell 132, 311-322 (2008).
21. Heintzman, N.D. et al. Histone modifications at human enhancers reflect global cell-type-specific gene expression. Nature 459, 108-112 (2009).
22. Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57-74 (2012).
23. Neph, S. et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83-90 (2012).
24. Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43-49 (2011).
25. Thurman, R.E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75-82 (2012).
26. Natoli, G. Maintaining cell identity through global control of genomic organization. Immunity 33, 12-24 (2010).
27. Ciofani, M. et al. A validated regulatory network for Th17 cell specification. Cell 151, 289-303 (2012).
28. Samstein, R.M. et al. Foxp3 exploits a pre-existent enhancer landscape for regulatory T cell lineage specification. Cell 151, 153-166 (2012).
29. Vahedi, G. et al. STATs shape the active enhancer landscape of T cell populations. Cell 151, 981-993 (2012).
30. Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576-589 (2010).
31. Jeong, K.W. et al. Recognition of enhancer element-specific histone methylation by TIP60 in transcriptional activation. Nat. Struct. Mol. Biol. 18, 1358-1365 (2011).
32. Cloos, P.A., Christensen, J., Agger, K. & Helin, K. Erasing the methyl mark: Histone demethylases at the center of cellular differentiation and disease. Genes Dev. 22, 1115-1140 (2008).
33. Burgess, R.J. & Zhang, Z. Histone chaperones in nucleosome assembly and human disease. Nat. Struct. Mol. Biol. 20, 14-22 (2013).
34. Elsaesser, S.J., Goldberg, A.D. & Allis, C.D. New functions for an old variant: No substitute for histone H3.3. Curr. Opin. Genet. Dev. 20, 110-117 (2010).
35. Dion, M.F. et al. Dynamics of replication-independent histone turnover in budding yeast. Science 315, 1405-1408 (2007).
36. Kouzarides, T. Chromatin modifications and their function. Cell 128, 693-705 (2007).
37. Tan, M. et al. Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification. Cell 146, 1016-1028 (2011).
38. Li, G. et al. Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation. Cell 148, 84-98 (2012).
39. Deng, W. et al. Controlling long-range genomic interactions at a native locus by targeted tethering of a looping factor. Cell 149, 1233-1244 (2012).
40. Cullen, K.E., Kladde, M.P. & Seyfred, M.A. Interaction between transcription regulatory regions of prolactin chromatin. Science 261, 203-206 (1993).
41. Dekker, J., Rippe, K., Dekker, M. & Kleckner, N. Capturing chromosome conformation. Science 295, 1306-1311 (2002).
42. de Wit, E. & de Laat, W. A decade of 3C technologies: Insights into nuclear organization. Genes Dev. 26, 11-24 (2012).
43. Tanay, A. & Cavalli, G. Chromosomal domains: Epigenetic contexts and functional implications of genomic compartmentalization. Curr. Opin. Genet. Dev. 23, 197-203 (2013).
44. Gibcus, J.H. & Dekker, J. The hierarchy of the 3D genome. Mol. Cell 49, 773-782 (2013).
45. Dixon, J.R. et al. Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature 485, 376-380 (2012).
46. Nora, E.P. et al. Spatial partitioning of the regulatory landscape of the X-inactivation centre. Nature 485, 381-385 (2012).
47. Sexton, T. et al. Three-dimensional folding and functional organization principles of the Drosophila genome. Cell 148, 458-472 (2012).
48. Tan-Wong, S.M., Wijayatilake, H.D. & Proudfoot, N.J. Gene loops function to maintain transcriptional memory through interaction with the nuclear pore complex. Genes Dev. 23, 2610-2624 (2009).
49. Deng, W. & Blobel, G.A. Do chromatin loops provide epigenetic gene expression states? Curr. Opin. Genet. Dev. 20, 548-554 (2010).
50. van de Werken, H.J. et al. Robust 4C-seq data analysis to screen for regulatory DNA interactions. Nat. Methods 9, 969-972 (2012).
51. Lieberman-Aiden, E. et al. Comprehensive mapping of long-range interactions reveals folding principles of the human genome. Science 326, 289-293 (2009).
52. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6-21 (2002).
53. Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129-1133 (2010).
54. Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930-935 (2009).
55. He, Y.F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303-1307 (2011).
56. Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300-1303 (2011).
57. Mellén, M., Ayata, P., Dewell, S., Kriaucionis, S. & Heintz, N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell 151, 1417-1430 (2012).
58. Yildirim, O. et al. Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells. Cell 147, 1498-1510 (2011).
59. Wu, H. et al. Dual functions of Tet1 in transcriptional regulation in mouse embryonic stem cells. Nature 473, 389-393 (2011).
60. Valinluck, V. & Sowers, L.C. Endogenous cytosine damage products alter the site selectivity of human DNA maintenance methyltransferase DNMT1. Cancer Res. 67, 946-950 (2007).
61. Guo, J.U., Su, Y., Zhong, C., Ming, G.L. & Song, H. Hydroxylation of 5-methylcytosine by TET1 promotes active DNA demethylation in the adult brain. Cell 145, 423-434 (2011).
62. Cortellino, S. et al. Thymine DNA glycosylase is essential for active DNA demethylation by linked deamination-base excision repair. Cell 146, 67-79 (2011).
63. Ficz, G. et al. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 473, 398-402 (2011).
64. Pastor, W.A. et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 473, 394-397 (2011).
65. Williams, K. et al. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 473, 343-348 (2011).
66. Xu, Y. et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42, 451-464 (2011).
67. Chen, Q., Chen, Y., Bian, C., Fujiki, R. & Yu, X. TET2 promotes histone O-GlcNAcylation during gene transcription. Nature 493, 561-564 (2013).
68. Vella, P. et al. Tet proteins connect the O-linked N-acetylglucosamine transferase Ogt to chromatin in embryonic stem cells. Mol. Cell 49, 645-656 (2013).
69. Dawlaty, M.M. et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9, 166-175 (2011).
70. Wu, H. et al. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 25, 679-684 (2011).
71. Spruijt, C.G. et al. Dynamic readers for 5-(hydroxy)methylcytosine and Its oxidized derivatives. Cell 152, 1146-1159 (2013).
72. Dawlaty, M.M. et al. Combined deficiency of tet1 and tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev. Cell 24, 310-323 (2013).
73. Ko, M. et al. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 108, 14566-14571 (2011).
74. Ko, M. et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 468, 839-843 (2010).
75. Koh, K.P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8, 200-213 (2011).
76. Li, Z. et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509-4518 (2011).
77. Moran-Crusio, K. et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 20, 11-24 (2011).
78. Cimmino, L., Abdel-Wahab, O., Levine, R.L. & Aifantis, I. TET family proteins and their role in stem cell differentiation and transformation. Cell Stem Cell 9, 193-204 (2011).
79. Gu, T.P. et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606-610 (2011).
80. Smith, Z.D. & Meissner, A. DNA methylation: Roles in mammalian development. Nat. Rev. Genet. 14, 204-220 (2013).
81. Kallin, E.M. et al. Tet2 facilitates the derepression of myeloid target genes during CEBPalpha-induced transdifferentiation of pre-B cells. Mol. Cell 48, 266-276 (2012).
82. Bruniquel, D. & Schwartz, R.H. Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process. Nat. Immunol. 4, 235-240 (2003).
83. Kersh, E.N. et al. Rapid demethylation of the IFN-? gene occurs in memory but not naive CD8 T cells. J. Immunol. 176, 4083-4093 (2006).
84. Rüegger, S. & Grosshans, H. MicroRNA turnover: When, how, and why. Trends Biochem. Sci. 37, 436-446 (2012).
85. Kai, Z.S. & Pasquinelli, A.E. MicroRNA assassins: Factors that regulate the disappearance of miRNAs. Nat. Struct. Mol. Biol. 17, 5-10 (2010).
86. Bhattacharyya, S.N., Habermacher, R., Martine, U., Closs, E.I. & Filipowicz, W. Relief of microRNA-mediated translational repression in human cells subjected to stress. Cell 125, 1111-1124 (2006).
87. Gatfield, D. et al. Integration of microRNA miR-122 in hepatic circadian gene expression. Genes Dev. 23, 1313-1326 (2009).
88. van Rooij, E. et al. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 316, 575-579 (2007).
89. Park, C.Y. et al. A resource for the conditional ablation of microRNAs in the mouse. Cell Rep 1, 385-391 (2012).
90. Leung, A.K. & Sharp, P.A. MicroRNA functions in stress responses. Mol. Cell 40, 205-215 (2010).
91. Hutvágner, G. & Zamore, P.D. A microRNA in a multiple-turnover RNAi enzyme complex.
92. Baccarini, A. et al. Kinetic analysis reveals the fate of a microRNA following target regulation in mammalian cells. Curr. Biol. 21, 369-376 (2011).
93. Chen, X., Liang, H., Zhang, J., Zen, K. & Zhang, C.Y. Secreted microRNAs: A new form of intercellular communication. Trends Cell Biol. 22, 125-132 (2012).
94. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2012).
95. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007).
96. Zhang, Y. et al. Secreted monocytic miR-150 enhances targeted endothelial cell migration. Mol. Cell 39, 133-144 (2010).
97. Rusca, N. et al. MiR-146a and NF-κB1 regulate mast cell survival and T lymphocyte differentiation. Mol. Cell Biol. 32, 4432-4444 (2012).
98. Taganov, K.D., Boldin, M.P., Chang, K.J. & Baltimore, D. NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486 (2006).
99. Yang, L. et al. miR-146a controls the resolution of T cell responses in mice. J. Exp. Med. 209, 1655-1670 (2012).
100. Boldin, M.P. et al. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med. 208, 1189-1201 (2011).
101. Zhao, J.L. et al. NF-κB dysregulation in microRNA-146a-deficient mice drives the development of myeloid malignancies. Proc. Natl. Acad. Sci. USA 108, 9184-9189 (2011).
102. Boldin, M.P. & Baltimore, D. MicroRNAs, new effectors and regulators of NF-κB. Immunol. Rev. 246, 205-220 (2012).
103. Montagner, S., Orlandi, E.M., Merante, S. & Monticelli, S. The role of miRNAs in mast cells and other innate immune cells. Immunol. Rev. (in the press) (2013).
104. Rodriguez, A. et al. Requirement of bic/microRNA-155 for normal immune function. Science 316, 608-611 (2007).
105. Thai, T.H. et al. Regulation of the germinal center response by microRNA-155. Science 316, 604-608 (2007).
106. Zheng, Q., Zhou, L. & Mi, Q.S. MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function. J. Immunol. 188, 2118-2126 (2012).
107. Mayoral, R.J. et al. MiR-221 influences effector functions and actin cytoskeleton in mast cells. PLoS ONE 6, e26133 (2011).
108. Rossato, M. et al. IL-10-induced microRNA-187 negatively regulates TNF-α, IL-6, and IL-12p40 production in TLR4-stimulated monocytes. Proc. Natl. Acad. Sci. USA 109, E3101-E3110 (2012).
109. ÓConnell, R.M., Chaudhuri, A.A., Rao, D.S. & Baltimore, D. Inositol phosphatase SHIP1 is a primary target of miR-155. Proc. Natl. Acad. Sci. USA 106, 7113-7118 (2009).
110. Bezman, N.A., Chakraborty, T., Bender, T. & Lanier, L.L. miR-150 regulates the development of NK and iNKT cells. J. Exp. Med. 208, 2717-2731 (2011).
111. Bronevetsky, Y. et al. T cell activation induces proteasomal degradation of Argonaute and rapid remodeling of the microRNA repertoire. J. Exp. Med. 210, 417-432 (2013).
112. Diederichs, S. & Haber, D.A. Dual role for argonautes in microRNA processing and posttranscriptional regulation of microRNA expression. Cell 131, 1097-1108 (2007).
113. ÓCarroll, D. et al. A Slicer-independent role for Argonaute 2 in hematopoiesis and the microRNA pathway. Genes Dev. 21, 1999-2004 (2007).
114. Olejniczak, S.H., La Rocca, G., Gruber, J.J. & Thompson, C.B. Long-lived microRNA-Argonaute complexes in quiescent cells can be activated to regulate mitogenic responses. Proc. Natl. Acad. Sci. USA 110, 157-162 (2013).
115. Chatterjee, S. & Grosshans, H. Active turnover modulates mature microRNA activity in Caenorhabditis elegans. Nature 461, 546-549 (2009).
116. Krol, J. et al. Characterizing light-regulated retinal microRNAs reveals rapid turnover as a common property of neuronal microRNAs. Cell 141, 618-631 (2010).
117. Hansen, T.B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384-388 (2013).
118. Thomas, M.F. et al. Eri1 regulates microRNA homeostasis and mouse lymphocyte development and antiviral function. Blood 120, 130-142 (2012).
119. Djebali, S. et al. Landscape of transcription in human cells. Nature 489, 101-108 (2012).
120. Guttman, M. & Rinn, J.L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339-346 (2012).
121. Wang, K.C. & Chang, H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 43, 904-914 (2011).
122. Ponting, C.P., Oliver, P.L. & Reik, W. Evolution and functions of long noncoding RNAs. Cell 136, 629-641 (2009).
123. Willingham, A.T. et al. A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science 309, 1570-1573 (2005).
124. Sharma, S. et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc. Natl. Acad. Sci. USA 108, 11381-11386 (2011).
125. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419 (2010).
126. Hung, T. et al. Extensive and coordinated transcription of noncoding RNAs within cell-cycle promoters. Nat. Genet. 43, 621-629 (2011).
127. Ørom, U.A. et al. Long noncoding RNAs with enhancer-like function in human cells. Cell 143, 46-58 (2010).
128. Gomez, J.A. et al. The NeST long ncRNA controls microbial susceptibility and epigenetic activation of the interferon-gamma locus. Cell 152, 743-754 (2013).
129. Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033-1038 (2010).
130. Salmena, L., Poliseno, L., Tay, Y., Kats, L. & Pandolfi, P.P. A ceRNA hypothesis: The Rosetta Stone of a hidden RNA language? Cell 146, 353-358 (2011).
131. Marangoni, F. et al. The transcription factor NFAT exhibits signal memory during serial T cell interactions with antigen-presenting cells. Immunity 38, 237-249 (2013). laboratory) laboratory)